New Key Statistics Module, Z-Score and F-Score
GREY:NWPHF Key Ratios
| Market Cap $ M | 199.37 |
| Enterprise Value $ M | 239.07 |
| P/E(ttm) | -- |
| PE Ratio without NRI | -- |
| Forward PE Ratio | 141.82 |
| Price/Book | -- |
| Price/Sales | 24.60 |
| Price/Free Cash Flow | -- |
| Price/Owner Earnings | -- |
| Payout Ratio % | -- |
| Revenue (TTM) $ M | 7.00 |
| EPS (TTM) $ | -1.12 |
| Beneish M-Score | -3.63 |
| 10-y EBITDA Growth Rate % | 4.40 |
| 5-y EBITDA Growth Rate % | 10.40 |
| y-y EBITDA Growth Rate % | -- |
| EV-to-EBIT | -15.01 |
| EV-to-EBITDA | -15.21 |
| PEG | -- |
| Shares Outstanding M | 19.23 |
| Net Margin (%) | -270.28 |
| Operating Margin % | -215.40 |
| Pre-tax Margin (%) | -269.90 |
| Quick Ratio | 3.73 |
| Current Ratio | 3.73 |
| ROA % (ttm) | -68.04 |
| ROE % (ttm) | -- |
| ROIC % (ttm) | -71.97 |
| Dividend Yield % | -- |
| Altman Z-Score | -0.80 |
NWPHF Number of Guru Trades
NWPHF Volume of Guru Trades
Gurus Latest Trades with GREY:NWPHF
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
GREY:NWPHF is held by these investors
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Newron Pharmaceuticals SpA Insider Transactions
No Available Data
News about GREY:NWPHF
Total 0- 1
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers